SunOpta Distribution reported earnings results for the third quarter and nine months ended September 30, 2009. For the quarter, the company reported revenue from external customers of $58.011 million and operating loss of $788,000 compared to the revenue from external customers of $62.693 million and operating income of $1.621 million for the same period a year ago. For nine months, the company reported revenue from external customers of $173.050 million and operating loss of $411,000 compared to the revenue from external customers of $201.116 million and operating income of $8.291 million for the same period a year ago.

SunOpta Inc. reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2009. The Company realized revenues of $253.8 million in the third quarter of 2009 versus third quarter 2008 revenues of $287.7 million, a year over year decrease of 11.8%. For the third quarter of 2009 the Company reported a loss on a GAAP basis of ($4.7) million or ($0.07) per diluted common share. Adjusted earnings(1) for the third quarter of 2009 were $4.4 million or $0.07 per diluted common share versus adjusted earnings(1) in the third quarter of 2008 of $5.2 million or $0.08 per diluted common share. Third quarter results include the impact of additional pre-tax costs of $10.6 million including net non-cash charges after minority interest of $4.8 million related to the impairment of goodwill in the Company's subsidiary, Opta Minerals Inc., pre-tax costs of $2.6 million related to ongoing product and facility rationalization efforts which includes non-cash charges of $1.0 million, pre-tax costs of $1.5 million related to the ongoing revitalization and re-launch of a number of company owned natural health products brands and additional legal, professional and banking fees of $1.7 million related to the 2007 restatement and class action settlement, a legal action in the SunOpta BioProcess Group and costs related to banking amendments. Adjusted earnings(1) excluding the impact of foreign exchange gains for the third quarter of 2009 were $3.8 million or $0.06 per diluted common share versus adjusted earnings(1) excluding the impact of foreign exchange of $2.4 million or $0.04 per diluted common share in the third quarter of 2008. The company reported loss before income taxes of $6.67 million compared to the income before income taxes of $5.451 million for the same period a year ago. The company reported that cash provided by operating activities of $19.266 million compared to the cash provided by operating activities of $23.704 million for the same period a year ago. The company announced net purchase of property, plant and equipment of $2.163 million compared to the net purchase of property, plant and equipment of $1.388 million for the same period a year ago. For the nine months ended September 30, 2009, the Company realized revenues of $743.6 million versus revenues of $810.1 million for the nine months ended September 30, 2008. After adjusting for revenue declines in non-core food operations and the impact on revenues due to changes in foreign exchange rates and commodity prices, food revenues have declined approximately 2% versus the same period in 2008. On a GAAP basis for the nine months ended September 30, 2009 the Company realized a loss of ($4.5) million or ($0.07) per diluted common share. Adjusted earnings(1) for the nine months ended September 30, 2009 were $9.0 million or $0.14 per diluted common share versus adjusted earnings(1) in the comparable period in 2008 of $13.5 million or $0.21 per diluted common share. The 2009 results include additional pre-tax costs of $17.3 million, including net non-cash charges of $4.8 million related to the impairment of goodwill in the Company's subsidiary, Opta Minerals Inc., pre-tax costs of $6.6 million related to ongoing product and facility rationalization efforts which includes non-cash charges of $1.0 million, pre-tax costs of $2.7 million related to the ongoing revitalization and re-launch of a number of company owned natural health products brands and additional legal, professional and banking fees of $3.2 million related to the 2007 restatement and class action settlement, a legal action in the SunOpta BioProcess Group and costs related to banking amendments. Adjusted earnings(1) excluding the impact of foreign exchange gains for the nine months ended September 30, 2009 were $8.7 million or $0.13 per diluted common share versus adjusted earnings(1) excluding the impact of foreign exchange of $10.0 million or $0.15 per diluted common share in the nine months ended September 30, 2008. The company reported loss before income taxes of $7.33 million compared to the income before income taxes of $9.839 million for the same period a year ago. The company reported that cash provided by operating activities of $26.221 million compared to the cash provided by operating activities of $12.736 million for the same period a year ago. The company announced net purchase of property, plant and equipment of $11.006 million compared to the net purchase of property, plant and equipment of $6.918 million for the same period a year ago. The company reported goodwill impairment of $8.341 million.

SunOpta Inc. announced that the company has entered into an amended and restated credit agreement with a syndicate of lenders, led by The Bank of Montreal as agent. The Facility provides for asset-based, revolving credit facilities of up to USD 80.0 million and CAD 20.0 million respectively, subject to borrowing base availability. The company will also have term debt outstanding under the Facility totaling USD 45.0 million. Revolving and non-revolving acquisition lines which existed in the company's previous facilities have been replaced by increased availability under the revolving credit lines in the new Facility. The Facility has a maturity of three years from the date of closing and provides borrowing capacity equal to amounts that existed under the previous loan agreement. Interest on borrowings under this Facility accrue at the company's option based on various reference rates including Canadian bank prime, U.S. bank prime and/or LIBOR, plus applicable margin, and it is anticipated that the company will realize lower borrowing rates versus current facilities based on revised interest rate grids associated with the new Facility combined with the effect of the company's improved financial position. The applicable margin is based on certain financial ratios, calculated in accordance with the terms of the Facility. The company's obligations under the Facility are collateralized by substantially all of its assets in which a security interest may lawfully be granted.